Data as of Nov 26
| +0.01 / +0.43%|
The 4 analysts offering 12-month price forecasts for Antares Pharma Inc have a median target of 5.00, with a high estimate of 6.00 and a low estimate of 4.00. The median estimate represents a +116.45% increase from the last price of 2.31.
The current consensus among 4 polled investment analysts is to Buy stock in Antares Pharma Inc. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.